Lecture: Changing the trajectory of heart failure - To help your patients endure
Opening & discussion
Heart failure - Current status in Hong Kong
Changing the course of heart failure
Hospitalisation and mortality in patients with heart failure treated with sacubitril/valsartan vs. enalapril - What does the real-world evidence show us?
This is an educational material to HCPs sponsored by Novartis Pharmaceuticals (HK) Ltd, for the purpose of continuing medical education only.